ANIX · Anixa Biosciences Inc

Anixa Biosciences Inc Is A Biotechnology Company Developing Therapies And Vaccines Focused On Critical Unmet Needs In Oncology. Its Operations Are Organized Into Reportable Segments Comprising Cancer Vaccines, Car-T Therapies, And Other. The Cancer Vaccines Segment Involves Vaccines To Treat And Prevent Breast And Ovarian Cancer, As Well As Additional Cancer Vaccines Targeting Intractable Cancers, Including High-Incidence Malignancies In Lung, Colon, And Prostate. The Car-T Therapies Segment Involves The Development Of Liraltagene Autoleucel (Lira-Cel), An Ovarian Cancer Immunotherapy Using Chimeric Endocrine Receptor-T Cell Technology, Developed At Its Subsidiary, Certainty Therapeutics, Inc. The Other Segment Consists Of Legacy Operations, Including Limited Patent Licensing Activities.